| __timestamp | ADMA Biologics, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 9689000 |
| Thursday, January 1, 2015 | 6745968 | 10431000 |
| Friday, January 1, 2016 | 8494742 | 9618000 |
| Sunday, January 1, 2017 | 18092835 | 12348000 |
| Monday, January 1, 2018 | 22502922 | 28310241 |
| Tuesday, January 1, 2019 | 25910757 | 59336147 |
| Wednesday, January 1, 2020 | 35050817 | 159145941 |
| Friday, January 1, 2021 | 42896889 | 199800000 |
| Saturday, January 1, 2022 | 52458024 | 90225000 |
| Sunday, January 1, 2023 | 59020000 | 92538000 |
Unleashing the power of data
In the competitive world of biotechnology, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: ADMA Biologics, Inc. and MorphoSys AG, from 2014 to 2023. Over this period, MorphoSys AG consistently outpaced ADMA Biologics in SG&A spending, peaking in 2021 with expenses nearly doubling those of ADMA. Notably, MorphoSys's SG&A expenses surged by over 1,900% from 2014 to 2021, reflecting strategic investments in expansion and R&D. Meanwhile, ADMA Biologics exhibited a steady increase, with a 1,100% rise, indicating a more conservative growth strategy. These trends highlight the diverse approaches to cost management within the biotech sector, offering valuable insights for investors and industry analysts alike.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG
Xenon Pharmaceuticals Inc. vs MorphoSys AG: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation
SG&A Efficiency Analysis: Comparing MorphoSys AG and Galapagos NV
Breaking Down SG&A Expenses: MorphoSys AG vs Novavax, Inc.